← Open Payments lookup

MELINDA GONZALEZ: Open Payments

NPI 1760651186 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,387 in 139 payments from 15 companies in 2025. Trend: 2023 $959 · 2024 $2,386 · 2025 $2,387

Food & beverage: $2,387
CompanyPaymentsAmount
ABBVIE INC.42$611
Madrigal Pharmaceuticals8$279
Ipsen Biopharmaceuticals, Inc16$211
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$178
Takeda Pharmaceuticals U.S.A., Inc.8$167
Lilly USA, LLC10$165
PFIZER INC.12$155
GENZYME CORPORATION5$145
Janssen Biotech, Inc.6$117
Phathom Pharmaceuticals, Inc.8$105

Products named: REZDIFFRA, IQIRVO, LINZESS, XIFAXAN, OMVOH, RINVOQ, ENTYVIO, DUPIXENT.

Industry payments across TX — which companies pay providers there.